News
Approximately two-thirds of patients responded to teduglutide, which is sold under the brand name Gattex as a treatment for ...
Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results